NGMBIO
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Oct 2025)
What this means for you
This application is over — abandoned 16 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97341671
- Mark type
- Design + words
- Filed
- 31 Mar 2022
- Published for opposition
- 11 Apr 2023
- Abandoned
- 16 Oct 2025
- Attorney of record
- Ilene B. Tannen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
- Class 044 — Medical, beauty and agricultural services: Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases
Owner
- NGM Biopharmaceuticals, Inc., South San Francisco, CA, US
- NGM Biopharmaceuticals, Inc., South San Francisco, CA, US
Prior registrations
Prosecution history
- 16 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2024 — SOU EXTENSION 3 GRANTED
- 18 Nov 2024 — SOU EXTENSION 3 FILED
- 18 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 24 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 May 2024 — SOU EXTENSION 2 GRANTED
- 23 May 2024 — SOU EXTENSION 2 FILED
- 23 May 2024 — SOU TEAS EXTENSION RECEIVED
- 21 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Nov 2023 — SOU EXTENSION 1 GRANTED
- 17 Nov 2023 — SOU EXTENSION 1 FILED
- 17 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 06 Jun 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT